scholarly journals Simultaneous thoracic endovascular aortic repair and endovascular aortic repair is feasible with minimal morbidity and mortality

2011 ◽  
Vol 54 (6) ◽  
pp. 1588-1591 ◽  
Author(s):  
Melissa L. Kirkwood ◽  
Alberto Pochettino ◽  
Ronald M. Fairman ◽  
Benjamin M. Jackson ◽  
Grace J. Wang ◽  
...  
Keyword(s):  
Thoracic Endovascular Aortic Repair ◽  
Endovascular Aortic Repair ◽  
Morbidity And Mortality ◽  
Minimal Morbidity ◽  
Aortic Repair

Effect of Resident Involvement on Morbidity and Mortality Following Thoracic Endovascular Aortic Repair

2018 ◽  
Vol 75 (6) ◽  
pp. 1575-1582 ◽  
Author(s):  
Derrick O. Acheampong ◽  
Philip Paul ◽  
Shanice Guerrier ◽  
Percy Boateng ◽  
I. Michael Leitman
Keyword(s):  
Thoracic Endovascular Aortic Repair ◽  
Endovascular Aortic Repair ◽  
Morbidity And Mortality ◽  
Aortic Repair ◽  
Resident Involvement

scholarly journals Treatment of Focal Aortic Disease by Thoracic Endovascular Aortic Repair Is Associated With High Success and Low Morbidity and Mortality

2015 ◽  
Vol 62 (3) ◽  
pp. 797-798
Author(s):  
Angela Crawford ◽  
Solomon Hayon ◽  
Michael Huffner ◽  
Angelina June ◽  
Behzad Farivar ◽  
...  
Keyword(s):  
Aortic Disease ◽  
Thoracic Endovascular Aortic Repair ◽  
Endovascular Aortic Repair ◽  
Morbidity And Mortality ◽  
Aortic Repair

scholarly journals Indications for Thoracic EndoVascular Aortic Repair (TEVAR): A Brief Review

2018 ◽  
Vol 27 (04) ◽  
pp. 177-184 ◽  
Author(s):  
Joshua Newman ◽  
Allan Mattia ◽  
Frank Manetta
Keyword(s):  
Mortality Rates ◽  
Thoracic Endovascular Aortic Repair ◽  
Aortic Aneurysms ◽  
Endovascular Aortic Repair ◽  
Morbidity And Mortality ◽  
Thoracic Aortic Aneurysms ◽  
Aortic Repair ◽  
Aortic Pathologies ◽  
The Ideal

The utility of Thoracic EndoVascular Aortic Repair (TEVAR) continues to progress at a very rapid rate. Initially implemented for the treatment of thoracic aortic aneurysms, TEVAR has evolved to treat a variety of aortic pathologies and reduce overall morbidity and mortality rates compared with traditional open surgical repair.Given the rapidly evolving nature of endovascular thoracic intervention, we hereby briefly review the current literature on the evolving applications of TEVAR.TEVAR continues to rapidly evolve and is being applied to a growing number of aortic pathologies. Given the perioperative, short- and mid-term morbidity and mortality rates, TEVAR is quickly surpassing traditional open surgical intervention as the ideal procedure for patients undergoing intervention of the descending thoracic aorta and applicability to ascending and arch pathologies is being explored. However, as more data becomes available TEVAR may be associated with higher rates of reoperative requirements. Data remains limited on the long-term efficacy of the intervention and should continue to be investigated.

Hypogastric Artery Stenting for Chronic Intermittent Spinal Cord Ischemia After Thoracic Endovascular Aortic Repair

2020 ◽  
Vol 27 (5) ◽  
pp. 801-804
Author(s):  
Catharina Gronert ◽  
Nikolaos Tsilimparis ◽  
Giuseppe Panuccio ◽  
Ahmed Eleshra ◽  
Fiona Rohlffs ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Ischemia ◽  
Thoracic Endovascular Aortic Repair ◽  
Neurological Symptoms ◽  
Endovascular Aortic Repair ◽  
Hypogastric Artery ◽  
Lower Extremity Weakness ◽  
Aortic Repair ◽  
The Right

Purpose: To report a case of chronic intermittent spinal cord ischemia (SCI) after thoracic endovascular aortic repair (TEVAR) and its successful treatment using hypogastric artery stenting. Case Report: A 79-year-old patient presented in May 2013 with a thoracic aortic aneurysm (TAA) and a contained rupture. He urgently underwent TEVAR that covered 274 mm of descending thoracic aorta without immediate postoperative signs of acute SCI. At 3-month follow-up, he reported repeating incidents of sudden lower extremity weakness leading to a fall with a humerus fracture. A neurological consultation revealed the tentative diagnosis of intermittent SCI caused by TEVAR and initially recommended a conservative approach. During the following year there was no clinical improvement of the symptoms. Computed tomography angiography showed a high-grade stenosis of the right hypogastric artery, which was stented in November 2014 to improve the collateral network of spinal cord perfusion. Following treatment, the patient had no further neurological symptoms; at 32 months after the reintervention, the imaging follow-up documented a patent stent and continued exclusion of the TAA. Conclusion: Intermittent neurological symptoms after TEVAR should be suspected as chronic intermittent SCI. The improvement of collateral networks of the spinal cord by revascularization of the hypogastric artery is a viable treatment option.

Sign in / Sign up

Export Citation Format

Share Document